.png){kind=icon}
返回
X
XA Li
chinese academy of sciences
4H指数
40论文数
101被引数
收录论文 12
发表时间
.png){kind=icon}
Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology/NSABP B-51/RTOG 1304.png)
CANCER RESEARCH.png)
CANCER RESEARCHIF16.6
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏NRG oncology/NSABP B-51/RTOG 1304: A phase III superiority clinical trial designed to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes and convert to ypN0 after neoadjuvant chemotherapy (NC)CANCER RESEARCH
CANCER RESEARCHIF16.6
PREAI
分享收藏NRG Oncology/NSABP B-51/RTOG 1304: A phase Ill clinical trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypNO after neoadjuvant chemotherapy (NC)CANCER RESEARCH
CANCER RESEARCHIF16.6
PREAI
分享收藏